These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 7719272)

  • 21. Nanoliposome-based antibacterial drug delivery.
    Hallaj-Nezhadi S; Hassan M
    Drug Deliv; 2015; 22(5):581-9. PubMed ID: 24313827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cationic liposomes as vaccine adjuvants.
    Christensen D; Korsholm KS; Rosenkrands I; Lindenstrøm T; Andersen P; Agger EM
    Expert Rev Vaccines; 2007 Oct; 6(5):785-96. PubMed ID: 17931158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liposomes as carriers of antigens and adjuvants.
    Alving CR
    J Immunol Methods; 1991 Jun; 140(1):1-13. PubMed ID: 1712030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends.
    Badiee A; Heravi Shargh V; Khamesipour A; Jaafari MR
    Vaccine; 2013 Jan; 31(5):735-49. PubMed ID: 23219436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Methods to increase the encapsulation efficiency for liposomal drugs].
    Kaszás N; Budai M; Budai L; Gróf P; Zimmer A; Klebovich I
    Acta Pharm Hung; 2008; 78(2):69-74. PubMed ID: 18807386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomal vaccines: clinical status and immunological presentation for humoral and cellular immunity.
    Alving CR
    Ann N Y Acad Sci; 1995 May; 754():143-52. PubMed ID: 7625648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linkup of a fast protein liquid chromatography system with a stirred thermostated cell for sterile preparation of liposomes by the proliposome-liposome method: application to encapsulation of antibiotics, synthetic peptide immunomodulators, and a photosensitizer.
    Turánek J; Záluská D; Neca J
    Anal Biochem; 1997 Jul; 249(2):131-9. PubMed ID: 9212864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination.
    Bal SM; Hortensius S; Ding Z; Jiskoot W; Bouwstra JA
    Vaccine; 2011 Jan; 29(5):1045-52. PubMed ID: 21129393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-circulating sterically stabilized liposomes in the treatment of infections.
    Bakker-Woudenberg IA; Schiffelers RM; Storm G; Becker MJ; Guo L
    Methods Enzymol; 2005; 391():228-60. PubMed ID: 15721385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications.
    Pinto-Alphandary H; Andremont A; Couvreur P
    Int J Antimicrob Agents; 2000 Jan; 13(3):155-68. PubMed ID: 10724019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential of Cationic Liposomes as Adjuvants/Delivery Systems for Tuberculosis Subunit Vaccines.
    Khademi F; Taheri RA; Momtazi-Borojeni AA; Farnoosh G; Johnston TP; Sahebkar A
    Rev Physiol Biochem Pharmacol; 2018; 175():47-69. PubMed ID: 29700609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases.
    Nisini R; Poerio N; Mariotti S; De Santis F; Fraziano M
    Front Immunol; 2018; 9():155. PubMed ID: 29459867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developments in liposomal drug delivery systems.
    Maurer N; Fenske DB; Cullis PR
    Expert Opin Biol Ther; 2001 Nov; 1(6):923-47. PubMed ID: 11728226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mannosylated liposomes for targeted vaccines delivery.
    Vyas SP; Goyal AK; Khatri K
    Methods Mol Biol; 2010; 605():177-88. PubMed ID: 20072881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposomes as nanovaccine delivery systems.
    Ghaffar KA; Giddam AK; Zaman M; Skwarczynski M; Toth I
    Curr Top Med Chem; 2014; 14(9):1194-208. PubMed ID: 24678703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators.
    Chauhan N; Tiwari S; Iype T; Jain U
    Expert Rev Vaccines; 2017 May; 16(5):491-502. PubMed ID: 28285554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulfated archaeal glycolipid archaeosomes as a safe and effective vaccine adjuvant for induction of cell-mediated immunity.
    McCluskie MJ; Deschatelets L; Krishnan L
    Hum Vaccin Immunother; 2017 Dec; 13(12):2772-2779. PubMed ID: 28537465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential use of liposome-mediated antiviral therapy.
    Koff WC; Fidler IJ
    Antiviral Res; 1985 Jun; 5(3):179-90. PubMed ID: 3896138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liposomal vaccines.
    Green S; Fortier A; Dijkstra J; Madsen J; Swartz G; Einck L; Gubish E; Nacy C
    Adv Exp Med Biol; 1995; 383():83-92. PubMed ID: 8644517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting strategies of liposomal subunit vaccine delivery systems to improve vaccine efficacy.
    Yu R; Mai Y; Zhao Y; Hou Y; Liu Y; Yang J
    J Drug Target; 2019 Aug; 27(7):780-789. PubMed ID: 30589361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.